CRDF 250516 2.50C(CRDF250516C2500) Stock Price Today

US OptionsDetailed Quotes

CRDF250516C2500

Watchlist

0.54
-0.06-10.00%

15min DelayClose May 2 15:59 ET

0.56High0.35Low

Intraday

5D
Daily

News

William Blair Maintains Cardiff Oncology(CRDF.US) With Buy Rating
Moomoo NewsApr 30 03:33 ET · Ratings
Promising Developments in Cardiff Oncology's Cancer Treatment Boost Buy Rating
TipRanksApr 29 14:15 ET
Cardiff Oncology Announces Second Patent for Onvansertib Combination
TipRanksApr 23 16:17 ET
Express News | Cardiff Oncology Announces a Second Patent for the Treatment of Mcrc for Bev-Naïve Patients
ReutersApr 23 16:05 ET
Craig-Hallum Maintains Cardiff Oncology(CRDF.US) With Buy Rating
Moomoo NewsApr 17 01:33 ET · Ratings
Analysts Offer Insights on Healthcare Companies: Cardiff Oncology (CRDF), UnitedHealth (UNH) and McKesson (MCK)
TipRanksApr 16 11:22 ET · Ratings

Comments

Trytosaveabit

Apr 24 04:10

news

$Cardiff Oncology (CRDF.US)$ Reuters· 3 mins ago
Cardiff Oncology Announces a Second Patent for the Treatment of Mcrc for Bev-Naïve Patients

Teddy123

Apr 16 13:13

Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer

$Cardiff Oncology (CRDF.US)$
Major Progress: First-line Colorectal Cancer Treatment Trial Hits Key Milestone

Jaguar8

Apr 16 04:05

NEWS

$Cardiff Oncology (CRDF.US)$
Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer
Tuesday, 15th April at 4:05 pm
- Initial results from randomized Phase 2 CRDF-004 trial in RAS-mut mCRC were released in December 2024 -
- Additional clinical data from CRDF-004 trial expected in 1H 2025 -
SAN DIEGO, April 15, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (NASDAQ: CRDF), a c...

clevertrader87

Jan 6 20:42

$Cardiff Oncology (CRDF.US)$ Arise you sleeping giant!! Arise!🏔️⌚👀

clevertrader87

Dec 17, 2024 23:14

Share Your Profit/Loss